- Home
- DX vs VCYT Comparison
DX vs VCYT Comparison
Compare DX & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DX | VCYT |
|---|---|---|
| Founded | 1987 | 2006 |
| Country | United States | United States |
| Employees | 22 | N/A |
| Industry | Real Estate Investment Trusts | Medical Specialities |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.8B |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | DX | VCYT |
|---|---|---|
| Price | $13.65 | $34.69 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 8 |
| Target Price | $14.25 | ★ $46.50 |
| AVG Volume (30 Days) | ★ 5.1M | 816.7K |
| Earning Date | 01-01-0001 | 05-25-2026 |
| Dividend Yield | ★ 14.91% | N/A |
| EPS Growth | N/A | ★ 164.52 |
| EPS | N/A | ★ 0.82 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $11.95 |
| Revenue Next Year | N/A | $11.97 |
| P/E Ratio | ★ $5.66 | $44.34 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.79 | $22.61 |
| 52 Week High | $14.93 | $50.71 |
Technical Indicators
Market Signals| Indicator | DX | VCYT |
|---|---|---|
| Relative Strength Index (RSI) | 35.37 | 40.87 |
| Support Level | $13.12 | $34.60 |
| Resistance Level | $13.72 | $34.89 |
| Average True Range (ATR) | 0.26 | 1.50 |
| MACD | -0.04 | 0.13 |
| Stochastic Oscillator | 13.77 | 11.02 |
Price Performance
Historical ComparisonAbout DX Dynex Capital Inc.
Dynex Capital Inc is an internally managed mortgage real estate investment trust, which invests in mortgage-backed securities. The company invests in residential and commercial mortgage-backed securities. Its objective is to provide attractive risk-adjusted returns to shareholders over the long term that are reflective of a leveraged, high quality fixed income portfolio with a focus on capital preservation. Its investments consist principally of Agency mortgage-backed securities including, residential MBS and commercial MBS.
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.